Persistent mitochondrial and endothelial dysfunction in non-hospitalized patients with Long COVID
Authors:
Open Access
- 20 August 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1921822
Abstract
Long COVID, a major post-acute infection syndrome (PAIS), characterized by prolonged or new-onset symptoms following acute COVID-19, critically affects patients' quality of life. Establishing easily measurable and objective biomarkers that reflect disease severity is essential for clinical management. This retrospective cohort study evaluated serum levels of growth differentiation factor 15 (GDF-15), a mitochondrial stress marker, and vascular cell adhesion molecule-1 (VCAM-1), a vascular endothelial stress marker, in 32 patients with Long COVID who presented with persistent systemic or neurological symptoms and had not required acute-phase hospitalization. Serum GDF-15, VCAM-1, and inflammatory cytokine levels were measured at the initial visit and at 3 and 6 months. Differences between patients who recovered at 6 months and those who did not (non-improved group) were analyzed using linear mixed-effects models (LMMs). Most inflammatory cytokines remained near their lower detection limits and were excluded from the longitudinal analysis. The LMMs revealed sustained elevation of both GDF-15 ( p = 0.02) and VCAM-1 ( p = 0.03) levels in the non-improved group. These findings suggest that longitudinal tracking of these two markers may offer clinically relevant insights into disease activity and treatment-resistant pathophysiology in mild acute-phase Long COVID.Keywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 35 references indexed in Scilit:
- Association of symptoms of neuropsychological long COVID with imaging and plasma biomarkersJournal of the Neurological Sciences, 2026
- Work Impairment and Financial Outcomes Among Adults With vs Without Long COVIDJAMA Network Open, 2025
- Novel biomarkers of mitochondrial dysfunction in Long COVID patientsGeroScience, 2024
- Prevalence, risk factors, and impact of long COVID in a socially vulnerable community in Brazil: a prospective cohort studyThe Lancet Regional Health - Americas, 2024
- ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disordersClinica Chimica Acta, 2023
- Inflammatory and vascular biomarkers in post‐COVID‐19 syndrome: A systematic review and meta‐analysis of over 20 biomarkersReviews in Medical Virology, 2023
- The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysiseClinicalMedicine, 2022
- Mitochondrial signal transductionCell Metabolism, 2022
- Multiple early factors anticipate post-acute COVID-19 sequelaeCell, 2022
- Vascular endotheliitis associated with infections: Its pathogenetic role and therapeutic implicationBiochemical Pharmacology, 2022